Asepto

Noida, India Founded: 2012 • Age: 14 yrs Listed
Manufactures aseptic cartons and filling machines for liquid packaging industries.
Request Access
Report Incorrect Data
Page last updated

About Asepto

Asepto is a publicly listed company based in Noida (India) founded in 2012. It manufactures aseptic cartons and filling machines for liquid packaging industries. It operates on a B2B and Manufacturing and Supply model in Industrial Goods & Manufacturing and Consumer sectors. The company has 5,482 employees. Its Indian entity Uflex Limited reported revenue of ₹15,530 Cr. Asepto offers products and services including Aseptic Cartons, SpeedPlus 25000, Flexpress 10000, and Asepto PRO. Its focus areas include Manufacturing, Packaging Machinery, Filling Machines and Aseptic Filling. Similar companies include Sweet Karam Coffee, Godrej Agrovet and Keventer; 3 of its 3 listed similar companies have raised funding.

Company details

Asepto, under UFlex Ltd., specializes in producing aseptic cartons and filling machines that preserve freshness of liquids like dairy and beverages. It operates through advanced manufacturing plants in India and Egypt, focusing on sustainable practices such as zero liquid discharge. The company serves businesses worldwide, supplying packaging solutions that ensure food safety and environmental responsibility, with innovations in recycled polymers and efficient machinery.

  • Headquarters Noida, India
  • Employees 5,482
  • Stage Public
  • Sectors
    Industrial Goods & Manufacturing
    Consumer
  • Phone
    •••• ••••
  • Website asepto.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Uflex Ltd.
  • Date of Incorporation 21 Jun, 1988
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Industrial Goods & Manufacturing → Packaging Equipment & Systems
Consumer → Food Packaging
Key Metrics
  • Market Cap
    ₹4,036 Cr

    UFLEX · NSE

  • Share Price
    ₹583.05

    +4.33% today

  • Revenue
    ₹15,401 Cr

    FY 2025-26 · +2.4% YoY

  • EBITDA
    ₹1,835 Cr

    Margin 11.9%

  • Net Profit
    ₹331 Cr

    FY 2025-26 · +43.9% YoY

  • P/E (TTM)
    5.9x

    P/B 0.5x

  • ROE
    4.2%

    ROCE 6.8%

  • Debt / Equity
    1.19

    Interest cover 74.2x

  • Employee Count
    5,482

Products & Services of Asepto

Asepto offers a comprehensive portfolio of products and services, including Aseptic Cartons, SpeedPlus 25000, Flexpress 10000, and Asepto PRO.

Aseptic Cartons
Packaging

Cartons that preserve freshness of liquid products like milk and juices.

SpeedPlus 25000
Filling Machines

High-speed machine for aseptic beverage packaging and processing.

Flexpress 10000
Filling Machines

Efficient filling system for various liquid packaging needs.

Asepto PRO
Technical Support

Support services for high-performance packaging machinery.

Apps and channels of Asepto

its YouTube channel ASEPTO - ASEPTIC LIQUID PACKAGING has 397 subscribers and 27 videos.

ASEPTO - ASEPTIC LIQUID PACKAGING
YouTube 397 subscribers 27 videos Science & Technology
Open channel

Videos from Asepto

The most watched videos on Asepto's YouTube channel, ASEPTO - ASEPTIC LIQUID PACKAGING (397 subscribers). Click a video to play it here.

Uflex Limited -Asepto -The first India Manufacturer of Aseptic Liquid Packaging
13.1K views
Asepto – Manufacturer of Liquid Cartons for Aseptic Packaging
5.4K views
Asepto Smart 78 - Filling Machine
1.7K views
Asepto – Manufacturer of Liquid Cartons for Aseptic Packaging
1.6K views

More on ASEPTO - ASEPTIC LIQUID PACKAGING.

Board of directors of Uflex Limited (Asepto)

Uflex Limited is the primary company behind Asepto. The board of Uflex Limited currently have 6 directors; the longest-serving is Ashok Chaturvedi, appointed in 1988. 25 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ashok Chaturvedi
DIN 00023452
Managing Director21 Jun 198838 yrs 4 moUflex Limited
Paresh Nath Sharma
DIN 00023625
Director11 Feb 20224 yrs 8 moUflex Limited
Sujit Kumar Varma
DIN 09075212
Director14 Feb 20233 yrs 8 moUflex Limited
Ghyanendra Nath Bajpai
DIN 00946138
Director17 Apr 20233 yrs 6 moUflex Limited
Rashmi Verma
DIN 01993918
Director26 May 20233 yrs 5 moUflex Limited
Jeevaraj Gopal Pillai
DIN 10381118
Whole-time director14 Nov 20232 yrs 11 moUflex Limited

People of Asepto

5 people are tracked at Asepto (2 in leadership, 3 in team); the tracked headcount is 5,482.

NameRoleGroup
Pragnesh Shah
Vice President OperationsLeadership
Ashwani Kumar Sharma
President & CEOLeadership
Ahetesham Shaikh
OfficerTeam
Ca. Gurjeet Singh
Business ControllerTeam
Paladugu Raghunath
OperationsTeam
Premium access

Complete people profiles for Asepto

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Asepto

Asepto is a publicly listed company on the NSE with ticker symbol UFLEX in India, operating in the Packaging sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: UFLEX
  • Listed entityUflex Limited
  • Exchange sectorPackaging

Financials of Asepto

Exchange-reported figures of Uflex Limited, the listed company behind Asepto (NSE: UFLEX).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹15,401 Cr
+2.4% YoY
EBITDA
₹1,835 Cr
+23.8% YoY
Profit After Tax
₹331 Cr
+43.9% YoY
Net Worth
₹8,122 Cr
+9.8% YoY
Total Assets
₹18,479 Cr
+16.0% YoY
Total Debt
₹10,152 Cr
+21.5% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue15,40115,03613,36414,66313,1278,8897,405
Revenue growth+2.4%+12.5%-8.9%+11.7%+47.7%+20.0%-
EBITDA1,8351,4824831,5992,1321,8011,080
EBITDA margin+11.9%+9.9%+3.6%+10.9%+16.2%+20.3%+14.6%
Profit before tax400264(549)6561,3821,142481
Net profit3312303585871,129845366
Net profit margin+2.2%+1.5%+2.7%+4.0%+8.6%+9.5%+4.9%
EPS (₹)43.9119.71(95.69)66.57152.09116.7351.21
Balance sheet
Total assets18,47915,93214,31213,33211,5839,6928,370
Net worth8,1227,3967,2257,5066,6965,5574,697
Total debt10,1528,3536,9475,7044,7874,0413,626
Cash & bank1,0721,1541,0731,091588616444
Net working capital5,6335,2594,9794,7664,1142,8972,215
Cash flow
Cash from operations9921,1358251,3837091,174849
Cash from investing(2,015)(1,732)(1,619)(1,172)(952)(1,095)(2,062)
Cash from financing9416787762922161341,369
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue5,3664,0563,6123,8323,9013,8143,7353,833
Revenue growth (YoY)+37.6%+6.3%-3.3%-0.0%+6.8%---
Other income32.0041.3920.8428.9521.2913265.2019.83
EBITDA889578424386454410454300
EBITDA margin+17.1%+14.6%+12.0%+10.3%+11.8%+10.9%+12.3%+7.9%
Depreciation213209202189187176172173
Interest216197193188199184174178
Profit before tax49121349.0937.7889.34182173(31.00)
Tax68.2916.9612.9910.9331.3613.3036.1133.58
Net profit42319636.1026.8557.98169137(64.58)
EPS (₹)58.6227.155.013.738.0323.3418.95(8.95)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue7,7787,7256,6106,7795,6744,6334,070
Revenue growth+0.7%+16.9%-2.5%+19.5%+22.5%+13.9%-
EBITDA832837729724633744534
EBITDA margin+10.7%+10.8%+11.0%+10.7%+11.2%+16.1%+13.1%
Profit before tax193274216317271354182
Net profit162213161242223232143
Net profit margin+2.1%+2.8%+2.4%+3.6%+3.9%+5.0%+3.5%
EPS (₹)20.5029.7022.2933.7530.7931.9119.84
Balance sheet
Total assets7,7046,9566,1945,4314,4753,7973,529
Net worth3,3753,2473,0442,9032,6822,4762,260
Total debt4,2683,6513,0852,4821,7521,2891,239
Cash & bank51871543124116420167.12
Net working capital2,8832,9142,4141,9211,4391,2731,004
Cash flow
Cash from operations651519434238376575317
Cash from investing(1,028)(451)(559)(679)(681)(292)(109)
Cash from financing179217314517268(149)(226)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue2,3441,9721,8161,9332,0581,9701,9391,956
Revenue growth (YoY)+13.9%+0.1%-6.4%-1.2%+10.6%---
Other income27.0417.7315.3925.2917.4541.5815.9313.44
Total expenses2,0851,7051,6421,7631,8271,7751,7011,754
EBITDA260267174170231195238202
EBITDA margin+11.4%+13.9%+9.7%+8.9%+11.4%+10.0%+12.6%+10.5%
Depreciation94.0094.0891.3880.6179.4479.0680.8780.61
Interest10999.4596.6890.4591.3779.6092.1182.76
Profit before tax84.0990.890.8624.2777.4677.8280.7751.82
Tax19.8024.54(1.35)1.9620.316.6123.0814.08

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 04 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue5,3664,0563,6123,8323,9013,8143,7353,833
Revenue growth (YoY)+37.6%+6.3%-3.3%-0.0%+6.8%---
Other income32.0041.3920.8428.9521.2913265.2019.83
EBITDA889578424386454410454300
EBITDA margin+17.1%+14.6%+12.0%+10.3%+11.8%+10.9%+12.3%+7.9%
Depreciation213209202189187176172173
Interest216197193188199184174178
Profit before tax49121349.0937.7889.34182173(31.00)
Tax68.2916.9612.9910.9331.3613.3036.1133.58
Net profit42319636.1026.8557.98169137(64.58)
EPS (₹)58.6227.155.013.738.0323.3418.95(8.95)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue15,40115,03613,36414,66313,1278,8897,405
Revenue growth+2.4%+12.5%-8.9%+11.7%+47.7%+20.0%-
Other income13017515912911025.9728.47
Total expenses13,56613,55412,88013,06310,9957,0886,324
Employee cost1,5651,3621,2021,079925799726
EBITDA1,8351,4824831,5992,1321,8011,080
EBITDA margin+11.9%+9.9%+3.6%+10.9%+16.2%+20.3%+14.6%
Depreciation787695655599537456403
Interest777698536473322229225
Profit before tax400264(549)6561,3821,142481
Tax72.24106142175283299110
Net profit3312303585871,129845366
Net profit margin+2.2%+1.5%+2.7%+4.0%+8.6%+9.5%+4.9%
EPS (₹)43.9119.71(95.69)66.57152.09116.7351.21
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital72.2172.2172.2172.2172.2172.2172.21
Reserves & surplus8,0507,3247,1537,4336,6245,4844,625
Shareholders' funds (net worth)8,1227,3967,2257,5066,6965,5574,697
Minority interest0.000.000.000.000.000.000.00
Secured loans9,2707,8046,3895,3574,4063,8313,384
Unsecured loans882548557346380210242
Total debt10,1528,3536,9475,7044,7874,0413,626
Total liabilities18,47915,93214,31213,33211,5839,6928,370
Assets
Gross block16,76314,61013,53112,45510,4388,5606,932
Net block9,7838,7398,2237,7866,4175,0323,808
Capital work in progress2,1767255384666711,5182,007
Investments116145170191212205199
Inventories2,4082,5351,9182,3111,8311,151855
Sundry debtors3,8613,7513,4373,2323,5112,4011,947
Cash & bank balances1,0721,1541,0731,091588616444
Loans & advances1,6471,0181,244935757561428
Total current assets8,9888,4587,6727,5696,6874,7293,674
Total current liabilities3,3563,1992,6932,8032,5731,8321,459
Net working capital5,6335,2594,9794,7664,1142,8972,215
Total assets18,47915,93214,31213,33211,5839,6928,370
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1,1541,0731,091588616402288
Net cash from operating activities9921,1358251,3837091,174849
Net cash from investing activities(2,015)(1,732)(1,619)(1,172)(952)(1,095)(2,062)
Net cash from financing activities9416787762922161341,369
Net change in cash(81.68)80.29(18.12)503(27.52)214155
Closing cash1,0721,1541,0731,091588616444
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+2.4%+12.5%-8.9%+11.7%+47.7%+20.0%-
EBITDA growth+23.8%+206.7%-69.8%-25.0%+18.4%+66.7%-
PBT growth+51.8%+9998.0%--52.5%+21.0%+137.5%+17.6%
Net income growth+43.9%-35.7%-39.0%-48.0%+33.6%+130.9%-
Revenue CAGR (3Y)+1.7%+4.6%+14.6%+25.6%+18.2%+9.3%+4.4%
EBITDA CAGR (3Y)+4.7%-11.4%-35.5%+14.0%+29.3%+27.0%+7.3%
Profitability & leverage
Net income margin+2.1%+1.1%-5.2%+3.3%+8.4%+9.5%+5.0%
Return on capital employed+6.8%+7.5%+6.4%+10.3%+16.0%+15.2%+9.5%
Return on net worth+4.2%+3.4%+4.9%+8.3%+18.0%+16.5%+8.2%
Debt / equity1.191.050.860.740.720.750.64
Long-term debt / equity0.860.750.630.530.530.560.37
Interest cover74.1788.69-310.8947.3420.2217.0333.20
Efficiency & per share
Fixed asset turnover0.981.071.031.281.381.151.09
Inventory turnover6.236.756.327.088.808.868.72
Debtors turnover4.054.184.014.354.444.093.71
EPS (₹)43.9119.71(95.69)66.57152.09116.7351.21
Dividend per share (₹)3.003.001.003.003.002.502.00
Book value per share (₹)1,124.811,024.281,000.531,039.38927.25769.49650.47
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue2,3441,9721,8161,9332,0581,9701,9391,956
Revenue growth (YoY)+13.9%+0.1%-6.4%-1.2%+10.6%---
Other income27.0417.7315.3925.2917.4541.5815.9313.44
Total expenses2,0851,7051,6421,7631,8271,7751,7011,754
EBITDA260267174170231195238202
EBITDA margin+11.4%+13.9%+9.7%+8.9%+11.4%+10.0%+12.6%+10.5%
Depreciation94.0094.0891.3880.6179.4479.0680.8780.61
Interest10999.4596.6890.4591.3779.6092.1182.76
Profit before tax84.0990.890.8624.2777.4677.8280.7751.82
Tax19.8024.54(1.35)1.9620.316.6123.0814.08
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue7,7787,7256,6106,7795,6744,6334,070
Revenue growth+0.7%+16.9%-2.5%+19.5%+22.5%+13.9%-
Other income84.6491.5741.3238.1246.8122.0582.65
Total expenses6,9466,8885,8816,0555,0413,8893,536
Employee cost751697619561507459462
EBITDA832837729724633744534
EBITDA margin+10.7%+10.8%+11.0%+10.7%+11.2%+16.1%+13.1%
Depreciation346320298262253260261
Interest378335256183155152173
Profit before tax193274216317271354182
Tax45.4659.3755.0773.3949.0912438.90
Net profit162213161242223232143
Net profit margin+2.1%+2.8%+2.4%+3.6%+3.9%+5.0%+3.5%
EPS (₹)20.5029.7022.2933.7530.7931.9119.84
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital72.2172.2172.2172.2172.2172.2172.21
Reserves & surplus3,3033,1752,9712,8312,6102,4042,187
Shareholders' funds (net worth)3,3753,2473,0442,9032,6822,4762,260
Secured loans3,8623,2832,7522,2961,5711,0941,008
Unsecured loans406368333186181196231
Total debt4,2683,6513,0852,4821,7521,2891,239
Total liabilities7,7046,9566,1945,4314,4753,7973,529
Assets
Gross block6,7786,1066,0545,3394,4574,2284,074
Net block3,4213,0113,1932,7352,0081,9782,019
Capital work in progress52034994.4527649570.8528.64
Investments420433442451466463462
Inventories882878751848712512481
Sundry debtors2,3972,3132,1442,0531,6941,3381,114
Cash & bank balances51871543124116420167.12
Loans & advances351242288232200225173
Total current assets4,1484,1483,6143,3742,7712,2761,836
Total current liabilities1,2641,2351,1991,4531,3321,004832
Net working capital2,8832,9142,4141,9211,4391,2731,004
Total assets7,7046,9566,1945,4314,4753,7973,529
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash71543124116420167.1285.27
Net cash from operating activities651519434238376575317
Net cash from investing activities(1,028)(451)(559)(679)(681)(292)(109)
Net cash from financing activities179217314517268(149)(226)
Net change in cash(198)28519076.59(36.26)134(18.15)
Closing cash51871543124116420167.12
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+0.7%+16.9%-2.5%+19.5%+22.5%+13.9%-
EBITDA growth-0.6%+14.9%+0.7%+14.4%-14.9%+39.4%-
PBT growth-29.3%+26.8%-31.9%+16.8%-23.4%+94.4%+150.6%
Net income growth-23.9%+32.1%-33.5%+8.6%-4.0%+61.8%-
Revenue CAGR (3Y)+4.7%+10.8%+12.6%+18.5%+10.4%+6.1%+1.5%
EBITDA CAGR (3Y)+4.8%+9.8%-0.7%+10.7%+11.3%+17.4%+2.7%
Profitability & leverage
Net income margin+1.9%+2.8%+2.4%+3.6%+3.9%+5.0%+3.5%
Return on capital employed+7.8%+9.3%+8.1%+10.1%+10.3%+13.8%+10.0%
Return on net worth+4.5%+6.8%+5.4%+8.7%+8.6%+9.7%+6.5%
Debt / equity1.201.070.940.760.590.530.60
Long-term debt / equity0.660.590.590.520.370.320.30
Interest cover77.6464.7559.4239.5540.8431.4463.47
Efficiency & per share
Fixed asset turnover1.211.271.161.381.311.121.04
Inventory turnover8.849.488.278.699.279.329.37
Debtors turnover3.303.473.153.623.743.783.54
EPS (₹)20.5029.7022.2933.7530.7931.9119.84
Dividend per share (₹)3.003.001.003.003.002.502.00
Book value per share (₹)467.43449.69421.49402.03371.43342.93312.91

Similar companies to Asepto

Asepto has 3 listed similar companies in our database, 3 of them funded. They include Sweet Karam Coffee, Godrej Agrovet and Keventer.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
Sweet Karam Coffee
sweetkaramcoffee.in2015Chennai, India$13.22M123
Dry snacks and coffee are manufactured and distributed.
Godrej Agrovet
godrejagrovet.com1992Mumbai, India$104.79M526
Diversified crop protection solutions are provided to farmers.
Keventer
keventer.com1986Kolkata, India$29.26M1,774
Multi-category food and beverage products are provided by Keventer.
Premium access

Detailed similar companies of Asepto

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Asepto

The website of Asepto (asepto.com) receives about 2.9K visits a month.

  • Monthly visits
    2.9K

    ▲ 90.6% vs previous month

Top companies in Packaging Equipment & Systems

3 companies that operate in the same segment as Asepto (Packaging Equipment & Systems) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
DCGpac
Packaging materials and supply-chain services are offered online to businesses.
2005Gurugram, Haryana, IndiaUSD 5.05 MUSD 10.95 M131
Dharaksha Ecosolutions
Biodegradable packaging materials are manufactured from crop stubble waste.
2020Delhi, Delhi, IndiaUSD 3.45 MUSD 45.41 K55
Zerocircle
Provider of seaweed-derived alternatives to plastics for films, coatings, and paper
2020Pune, Maharashtra, IndiaUSD 4.9 MUSD 66.27 K
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Asepto

Uflex-Spectra Systems submit bid for RBI’s proposed polymer banknote programme: Report - CNBC TV18
CNBCTV18 • 1 month ago
Uflex, US firm Spectra enters race for proposed polymer banknote programme | Economy & Policy News - Business Standard
Business Standard • 1 month ago
UFlex Egypt plant: UFlex Asepto’s Egypt Bet: 12 Billion Packs, Global Markets - The Economic Times Video | ET Now
Economic Times • 1 month ago
UFlex secures Indian patent for aseptic liquid packaging machine
Packaging Gateway • 1 month ago
Uflex: Company Receives 20-Year Patent For Fast Aseptic Packaging Machine
Exchange Update • 1 month ago
UFlex: UFlex’s Asepto bets on Egypt to build global aseptic packaging hub - The Economic Times
Economic Times • 1 month ago
UFlex’s Asepto targets global markets with Egypt plant - Industry News | The Financial Express
Financial Express • 1 month ago
UFLEX: Q1 FY 2027 saw 38% revenue and 92% EBITDA growth, with strong overseas-driven margins
Quartr • 2 months ago
UFLEX: Q1 FY27 saw record EBITDA margin and robust growth, driven by global expansion and efficiency
Quartr • 2 months ago
UFLEX: Q1 FY27 saw robust revenue and profit growth, with new recycling operations and ongoing tax appeals
Quartr • 2 months ago
Premium access

Complete news archive for Asepto

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asepto

Asepto was founded in 2012.

Asepto is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.

Asepto has 5,482 employees.

The primary company behind Asepto, Uflex Limited, reported revenue of ₹15,530 Cr for FY 2026, up 2% year on year.

Asepto, under UFlex Ltd., specializes in producing aseptic cartons and filling machines that preserve freshness of liquids like dairy and beverages. It operates through advanced manufacturing plants in India and Egypt, focusing on sustainable practices such as zero liquid discharge. The company serves businesses worldwide, supplying packaging solutions that ensure food safety and environmental responsibility, with innovations in recycled polymers and efficient machinery.

Asepto's top competitors include Sweet Karam Coffee, Keventer and Godrej Agrovet.

Asepto offers Aseptic Cartons, SpeedPlus 25000, Flexpress 10000, and Asepto PRO.

Yes, Asepto is publicly traded on NSE under the ticker symbol UFLEX.

Asepto operates through Uflex Limited.

The legal entities of Asepto currently have 8 directors, including Ashok Chaturvedi, Paresh Nath Sharma, Sujit Kumar Varma and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available